Cargando…
Proteomic Analysis of Glioma Chemoresistance
Malignant glioma is the most common and destructive form of primary brain tumor. Along with surgery and radiation, chemotherapy remains as the major treatment modality. The emergence of drug resistance, however, often leads to a therapeutic failure in the treatment of glioma, precluding long-term su...
Autor principal: | Suk, Kyoungho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286849/ https://www.ncbi.nlm.nih.gov/pubmed/22942880 http://dx.doi.org/10.2174/157015912799362733 |
Ejemplares similares
-
Pyruvate Dehydrogenase Kinase as a Potential Therapeutic Target for Malignant Gliomas
por: Jha, Mithilesh Kumar, et al.
Publicado: (2013) -
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
por: Orza, Anamaria, et al.
Publicado: (2013) -
Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma
por: Levenson, Cathy W., et al.
Publicado: (2019) -
Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production
por: Oliva, Claudia R., et al.
Publicado: (2011) -
Induction of the Unfolded Protein Response Drives Enhanced Metabolism and Chemoresistance in Glioma Cells
por: Epple, Laura M., et al.
Publicado: (2013)